# Haemonetics Corp: filings

HAE · NYSE · CIK 313143 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Apr 3

Pages: [Overview](/companies/hae.md) · [Financials](/companies/hae/financials.md) · [Filings](/companies/hae/filings.md) · [Insiders](/companies/hae/insiders.md)

## Reports and events: 277 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 866, 8-K 182, SC 13G/A 67, 10-Q 53, 3 41, 144 26, 10-K 18, DEF 14A 18, DEFA14A 15, SC 13G 13, SD 13, UPLOAD 9, CORRESP 7, S-8 7, SCHEDULE 13G/A 7, 4/A 6, 8-K/A 6, SC TO-T/A 6, ARS 4, SCHEDULE 13G 4, PRE 14A 3, 5 2, CT ORDER 2, SC TO-C 2, 3/A 1, EFFECT 1, NO ACT 1, POS AM 1, SC TO-T 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-08 | 10:15 ET | [8-K](/filings/0000313143-26-000138.md) | 7.01 Regulation FD disclosure | 0000313143-26-000138 |
| 2026-08-18 | 10:03 ET | [8-K](/filings/0000313143-26-000135.md) | 7.01 Regulation FD disclosure | 0000313143-26-000135 |
| 2026-08-06 | 10:09 ET | [10-Q](/filings/0000313143-26-000120.md) | Quarterly report, period 2026-06-27 | 0000313143-26-000120 |
| 2026-08-06 | 10:07 ET | [8-K](/filings/0000313143-26-000118.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-26-000118 |
| 2026-07-28 | 20:28 ET | [8-K](/filings/0000313143-26-000095.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000313143-26-000095 |
| 2026-06-09 | 20:17 ET | [DEF 14A](/filings/0000313143-26-000074.md) | Proxy statement, period 2026-03-28 | 0000313143-26-000074 |
| 2026-06-05 | 10:33 ET | [8-K](/filings/0000313143-26-000057.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000313143-26-000057 |
| 2026-05-20 | 10:31 ET | [10-K](/filings/0000313143-26-000050.md) | Annual report, period 2026-03-28 | 0000313143-26-000050 |
| 2026-05-07 | 10:02 ET | [8-K](/filings/0000313143-26-000031.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-26-000031 |
| 2026-05-01 | 20:18 ET | [8-K](/filings/0000313143-26-000023.md) | 5.02 Departure or appointment of officers or directors | 0000313143-26-000023 |
| 2026-03-03 | 11:09 ET | [8-K](/filings/0000313143-26-000017.md) | 7.01 Regulation FD disclosure | 0000313143-26-000017 |
| 2026-02-12 | 21:15 ET | [8-K](/filings/0000313143-26-000014.md) | 7.01 Regulation FD disclosure | 0000313143-26-000014 |
| 2026-02-05 | 11:05 ET | [10-Q](/filings/0000313143-26-000010.md) | Quarterly report, period 2025-12-27 | 0000313143-26-000010 |
| 2026-02-05 | 11:03 ET | [8-K](/filings/0000313143-26-000009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-26-000009 |
| 2026-01-09 | 11:17 ET | [8-K](/filings/0000313143-26-000003.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000313143-26-000003 |
| 2025-11-06 | 11:03 ET | [10-Q](/filings/0000313143-25-000075.md) | Quarterly report, period 2025-09-27 | 0000313143-25-000075 |
| 2025-11-06 | 11:01 ET | [8-K](/filings/0000313143-25-000074.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-25-000074 |
| 2025-08-07 | 10:08 ET | [10-Q](/filings/0000313143-25-000058.md) | Quarterly report, period 2025-06-28 | 0000313143-25-000058 |
| 2025-08-07 | 10:04 ET | [8-K](/filings/0000313143-25-000056.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-25-000056 |
| 2025-07-25 | 20:16 ET | [8-K](/filings/0000313143-25-000047.md) | 5.07 Shareholder vote results | 0000313143-25-000047 |
| 2025-06-06 | 20:17 ET | [DEF 14A](/filings/0000313143-25-000041.md) | Proxy statement, period 2025-03-29 | 0000313143-25-000041 |
| 2025-05-21 | 10:12 ET | [10-K](/filings/0000313143-25-000025.md) | Annual report, period 2025-03-29 | 0000313143-25-000025 |
| 2025-05-08 | 10:03 ET | [8-K](/filings/0000313143-25-000021.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0000313143-25-000021 |
| 2025-03-03 | 21:13 ET | [8-K](/filings/0000313143-25-000015.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000313143-25-000015 |
| 2025-02-06 | 11:20 ET | [10-Q](/filings/0000313143-25-000012.md) | Quarterly report, period 2024-12-28 | 0000313143-25-000012 |
| 2025-02-06 | 11:19 ET | [8-K](/filings/0000313143-25-000011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-25-000011 |
| 2025-01-14 | 11:21 ET | [8-K](/filings/0000313143-25-000006.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000313143-25-000006 |
| 2025-01-03 | 11:08 ET | [8-K](/filings/0000313143-25-000003.md) | 5.02 Departure or appointment of officers or directors | 0000313143-25-000003 |
| 2024-12-03 | 11:07 ET | [8-K](/filings/0000313143-24-000066.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000313143-24-000066 |
| 2024-11-07 | 11:11 ET | [10-Q](/filings/0000313143-24-000063.md) | Quarterly report, period 2024-09-28 | 0000313143-24-000063 |
| 2024-11-07 | 11:03 ET | [8-K](/filings/0000313143-24-000060.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-24-000060 |
| 2024-09-16 | 20:17 ET | [8-K](/filings/0000313143-24-000056.md) | 5.02 Departure or appointment of officers or directors | 0000313143-24-000056 |
| 2024-08-08 | 10:05 ET | [10-Q](/filings/0000313143-24-000054.md) | Quarterly report, period 2024-06-29 | 0000313143-24-000054 |
| 2024-08-08 | 10:04 ET | [8-K](/filings/0000313143-24-000053.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-24-000053 |
| 2024-07-30 | 20:23 ET | [8-K/A](/filings/0000313143-24-000047.md) | 5.07 Shareholder vote results | 0000313143-24-000047 |
| 2024-07-25 | 20:10 ET | [8-K](/filings/0000313143-24-000044.md) | 5.07 Shareholder vote results | 0000313143-24-000044 |
| 2024-06-07 | 10:26 ET | [DEF 14A](/filings/0000313143-24-000040.md) | Proxy statement, period 2024-03-30 | 0000313143-24-000040 |
| 2024-05-29 | 20:06 ET | [8-K](/filings/0001104659-24-066056.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-24-066056 |
| 2024-05-23 | 10:03 ET | [8-K](/filings/0001104659-24-064437.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-064437 |
| 2024-05-21 | 20:06 ET | [8-K](/filings/0001104659-24-063835.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-063835 |
| 2024-05-20 | 10:16 ET | [10-K](/filings/0000313143-24-000020.md) | Annual report, period 2024-03-30 | 0000313143-24-000020 |
| 2024-05-09 | 10:04 ET | [8-K](/filings/0000313143-24-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-24-000015 |
| 2024-05-01 | 20:12 ET | [8-K](/filings/0000950103-24-006128.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950103-24-006128 |
| 2024-04-01 | 12:01 ET | [8-K](/filings/0000313143-24-000012.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000313143-24-000012 |
| 2024-03-05 | 11:10 ET | [8-K](/filings/0000313143-24-000009.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000313143-24-000009 |
| 2024-02-08 | 11:06 ET | [10-Q](/filings/0000313143-24-000007.md) | Quarterly report, period 2023-12-30 | 0000313143-24-000007 |
| 2024-02-08 | 11:05 ET | [8-K](/filings/0000313143-24-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-24-000006 |
| 2023-12-12 | 11:09 ET | [8-K](/filings/0000313143-23-000060.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000313143-23-000060 |
| 2023-11-02 | 10:19 ET | [10-Q](/filings/0000313143-23-000057.md) | Quarterly report, period 2023-09-30 | 0000313143-23-000057 |
| 2023-11-02 | 10:16 ET | [8-K](/filings/0000313143-23-000056.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000313143-23-000056 |

Page 1 of 6. [Older](/companies/hae/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:55 ET. No prices; not investment advice.